Plain-English translation of NCT07454499 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a smartphone app can help women with early-stage hormone receptor–positive breast cancer stay on their oral endocrine therapy and manage the side effects that come with it. The app lets you track your symptoms and get support throughout your treatment. Half of participants will use the app, and half will receive standard educational materials about their medication.
Many women stop taking this treatment early because of side effects or other challenges, even though staying on the medication for the full course significantly improves long-term survival. This trial wants to see if a smartphone-based tool can help you stay on track with your treatment and feel better while taking it.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to either use a symptom-tracking app on your smartphone or receive an educational handout about your medication. Those using the app will monitor their side effects and get health tips through their phone. The study will track how well you stick with your hormone therapy over time and compare the two groups to see if the app helps. You'll need to have a smartphone and be able to use an electronic pill bottle to track your medication.
AI-generated summary from trial data · Jun 30, 2026 · Not medical advice
United States